ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Surescripts E-Prescribing Expands to Veterinary Medications

Surescripts®, the nation’s leading health information network, is expanding its E-Prescribing service to include medications ordered by veterinarians through a new partnership with DAW Systems, Inc. (ScriptSure). Surescripts E-Prescribing for Veterinary Medications will provide quicker time to therapy, improved medication adherence and ultimately better care for pets.

“Our work with DAW Systems to bring the benefits of electronic prescribing to veterinarians is yet another example of our commitment to partnership and innovation across the Surescripts Network Alliance,” said Frank Harvey, Chief Executive Officer for Surescripts. “This technology, which has supported clinicians for more than two decades, will also support veterinarians by reducing administrative tasks—like handwritten prescriptions, phone calls and faxes—so they can spend more meaningful time caring for our pet patients.”

“We are excited to expand the benefits of Surescripts E-Prescribing beyond human patients to our animal patients and the veterinarians who care for them,” said Adam Forman, Chief Operating Officer at DAW Systems, Inc. (ScriptSure). “Together with Surescripts, we will enable veterinarian prescribers to securely transmit electronic prescriptions to retail pharmacies, streamlining the prescription process for pets, enhancing patient safety and reducing the potential for medication errors.”

Surescripts E-Prescribing for Veterinary Medications will be available on the NCPDP SCRIPT Standard Version 2023011, which was finalized by the Centers for Medicare and Medicaid Services (CMS) in June 2024.

“This means participants in the Surescripts Network Alliance who complete their E-Prescribing upgrade and add E-Prescribing for Veterinary Medications will gain access to trusted, advanced prescribing tools that emphasize better quality care and prioritize patient safety,” said Kat Thorp, Vice President of Product Commercialization for Surescripts.

In 2023, Surescripts processed 2.5 billion e-prescriptions from 1.29 million prescribers across the U.S. More information about the upgrades is available at https://surescripts.com/NCPDP-2023-upgrade.

About Surescripts

Our purpose is to serve the nation through simpler, trusted health intelligence sharing, in order to increase patient safety, lower costs and ensure quality care. At Surescripts, we align healthcare organizations across the nation and convene the Surescripts Network Alliance® to give healthcare professionals the trusted insights they need to serve patients. Together, we’re making interoperability an everyday reality, making it simpler to choose medications patients can afford and adhere to, and getting specialty medications to patients more efficiently. Visit us at surescripts.com and follow us on LinkedIn.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.